Behaviour and significance of reservoir evaporation and seepage losses – an experience of four reservoirs in Damodar River Valley, India by Dipankar Chaudhuri (498103)

“…Frequency of seepage varied significantly with the season or month. It increased noticeably with rise of operating level. …”

CSB elemental content. by Shiqi Zhang (709298)

Subjects:

Changes in rumen fluid metabolites. by Shiqi Zhang (709298)

Subjects:

Rumen fermentation parameters. by Shiqi Zhang (709298)

Subjects:

Rumen microflora gene primer information. by Shiqi Zhang (709298)

Subjects:

Feed nutrient disappearance rate. by Shiqi Zhang (709298)

Subjects:

Rumen bacterial and archaeal diversity. by Shiqi Zhang (709298)

Subjects:

Key significant pathways in the final models of self-compassion. by Eriko Takahashi (22608061)

Subjects:

Fig 5 - by Yong-Rae Kim (19797278)

Subjects:

Receiver operating characteristic curve analyses for the prediction of hepatitis C. by Lu Han (151620)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Exploring the correlation between systemic inflammation biomarkers and HCV infection (logarithm base 2). by Lu Han (151620)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

Threshold effect analysis of systemic inflammatory biomarkers on hepatitis C using two-piece wise linear regression. by Lu Han (151620)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Exclusion and enrollment summary from NHANES. by Lu Han (151620)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects: